Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Faye Vazvaei

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
The AAPS Journal|September 27, 2022
Neutralization Activity of Anti-drug Antibodies Against a Biotherapeutic Can Be Predicted from a Comprehensive Pharmacokinetics, Pharmacodynamics, and Anti-drug Antibody Data AnalysisWeifeng Xu, Brian Maas, Brad Roadcap, et al.
Neuro-Oncology|May 9, 2020
Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoproteinHolger Fischer, Mohammed Ullah, Cecile C de la Cruz, et al.
The AAPS Journal|November 14, 2014
Recommendations for validation of LC-MS/MS bioanalytical methods for protein biotherapeuticsRand Jenkins, Jeffrey X Duggan, Anne-Françoise Aubry, et al.
Analytical Chemistry|December 26, 2017
Sensitive, High-Throughput, and Robust Trapping-Micro-LC-MS Strategy for the Quantification of Biomarkers and Antibody BiotherapeuticsMing Zhang, Bo An, Yang Qu, et al.
Clinical Pharmacology and Therapeutics|December 11, 2023
Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working GroupWenkui Li, Faye Vazvaei-Smith, Gordon Dear, et al.
Analytical Chemistry|February 5, 2019
High-Throughput, Sensitive LC-MS Quantification of Biotherapeutics and Biomarkers Using Antibody-Free, Peptide-Level, Multiple-Mechanism Enrichment via Strategic Regulation of pH and Ionic and Solvent StrengthsBo An, Ming Zhang, Jie Pu, et al.
The AAPS Journal|March 12, 2025
Best Practices and Recommendations for Non-Liquid Matrices BioanalysisFaye Vazvaei-Smith, Wenkui Li, Omar S Barnaby, et al.
Bioanalysis|December 16, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 1--small molecules by LCMS)Eric Fluhler, Roger Hayes, Fabio Garofolo, et al.
Bioanalysis|December 24, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 3 - LBA and immunogenicity)Lauren Stevenson, Lakshmi Amaravadi, Heather Myler, et al.
Bioanalysis|December 23, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 2 - hybrid LBA/LCMS, ELN & regulatory agencies' input)Dawn Dufield, Hendrik Neubert, Fabio Garofolo, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The AAPS Journal|September 27, 2022
Neutralization Activity of Anti-drug Antibodies Against a Biotherapeutic Can Be Predicted from a Comprehensive Pharmacokinetics, Pharmacodynamics, and Anti-drug Antibody Data AnalysisWeifeng Xu, Brian Maas, Brad Roadcap, et al.
Neuro-Oncology|May 9, 2020
Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoproteinHolger Fischer, Mohammed Ullah, Cecile C de la Cruz, et al.
The AAPS Journal|November 14, 2014
Recommendations for validation of LC-MS/MS bioanalytical methods for protein biotherapeuticsRand Jenkins, Jeffrey X Duggan, Anne-Françoise Aubry, et al.
Analytical Chemistry|December 26, 2017
Sensitive, High-Throughput, and Robust Trapping-Micro-LC-MS Strategy for the Quantification of Biomarkers and Antibody BiotherapeuticsMing Zhang, Bo An, Yang Qu, et al.
Clinical Pharmacology and Therapeutics|December 11, 2023
Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working GroupWenkui Li, Faye Vazvaei-Smith, Gordon Dear, et al.
Analytical Chemistry|February 5, 2019
High-Throughput, Sensitive LC-MS Quantification of Biotherapeutics and Biomarkers Using Antibody-Free, Peptide-Level, Multiple-Mechanism Enrichment via Strategic Regulation of pH and Ionic and Solvent StrengthsBo An, Ming Zhang, Jie Pu, et al.
The AAPS Journal|March 12, 2025
Best Practices and Recommendations for Non-Liquid Matrices BioanalysisFaye Vazvaei-Smith, Wenkui Li, Omar S Barnaby, et al.
Bioanalysis|December 16, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 1--small molecules by LCMS)Eric Fluhler, Roger Hayes, Fabio Garofolo, et al.
Bioanalysis|December 24, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 3 - LBA and immunogenicity)Lauren Stevenson, Lakshmi Amaravadi, Heather Myler, et al.
Bioanalysis|December 23, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 2 - hybrid LBA/LCMS, ELN & regulatory agencies' input)Dawn Dufield, Hendrik Neubert, Fabio Garofolo, et al.
Pageof 3